Veracyte ($VCYT) Insider Trading & Smart Money Activity
Veracyte, Inc. ($VCYT) has 7 insider trades, 2 13F position changes and 1 analyst rating on file. In the last 12 months on the open market, no insider bought and 2 insiders sold ($357.82K), net -$357.82K.
- Insider buyers (12 mo)
- 0
- Insider sellers (12 mo)
- 2
- Net insider $ (12 mo)
- -$357.82K
- Congress trades (12 mo)
- 0
- 13F moves on file
- 2
- Analyst ratings on file
- 1
VCYT insider buying and selling by quarter
| Quarter | Insider buys | Insider sales | Congress buys / sales | 13F added / cut |
|---|---|---|---|---|
| Q1 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q2 2026 | 0 | 1 · $197.22K | 0 / 0 | 0 / 2 |
| Q3 2026 | 0 | 1 · $160.60K | 0 / 0 | 0 / 0 |
| Q4 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.
All VCYT insider, congress, 13F and analyst activity
| Date | Source | Who | Action | Shares | Value / amount | ΔOwn | 1W | 1M | 6M | Filing | Story |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Insider | Leite JohnGlobal Chief Commercial Off | Sell (Open-market sale) 10b5-1 | 4.01K sh | $160.60K | +8.9% | — | |||||
| Analyst | Guggenheim | Reiterates to buy | PT $65 | -3.7% | -7.4% | Read | |||||
| Insider | Karin Eastham | Sell (Open-market sale) 10b5-1 | 3.73K sh | $197.22K | +9.2% | +6.8% | Read | ||||
| Insider | Shafer David Brent | Buy (Grant or award) | 5.27K sh | +13.1% | +21.2% | Read | |||||
| Insider | Jones Evan/ Fa | Buy (Grant or award) | 5.27K sh | +13.1% | +21.2% | — | |||||
| Insider | Robert Epstein | Buy (Grant or award) | 5.27K sh | +13.1% | +21.2% | — | |||||
| Insider | Muna Bhanji | Buy (Grant or award) | 5.27K sh | +13.1% | +21.2% | — | |||||
| Insider | Eliav Barr | Buy (Grant or award) | 5.27K sh | +13.1% | +21.2% | — | |||||
| 13F | ARK Investment Management | Reduced | -833.73K sh | $179.35M | +5.4% | +19.9% | Read | ||||
| 13F | ARK Investment Management | Reduced | -833.73K sh | $144.54M | +5.4% | +19.9% | — |
1W / 1M / 6M = how VCYT moved from the trade or filing date.
Insider trading in VCYT: who is buying and selling
| Insider | Role | Trades | Open-market net | Shares held | Last trade |
|---|---|---|---|---|---|
| Leite John | Global Chief Commercial Off | 1 | -$160.60K | Sep 21, 2026 | |
| Karin Eastham | 1 | -$197.22K | Jun 18, 2026 | ||
| Shafer David Brent | 1 | — | Jun 11, 2026 | ||
| Jones Evan/ Fa | 1 | — | Jun 11, 2026 | ||
| Robert Epstein | 1 | — | Jun 11, 2026 | ||
| Muna Bhanji | 1 | — | Jun 11, 2026 | ||
| Eliav Barr | 1 | — | Jun 11, 2026 |
Institutions moving VCYT (13F)
Analyst ratings on VCYT
| Date | Firm | Action | Rating | Price target | 1W | 1M | 6M | Story |
|---|---|---|---|---|---|---|---|---|
| Guggenheim | Reiterates | buy | $65 | -3.7% | -7.4% | Read |
Frequently asked questions
Are VCYT insiders buying or selling?
Over the last 12 months 0 insiders made 0 open-market purchases worth $0 and 2 insiders made 2 open-market sales worth $357.82K, a net -$357.82K.
What is the latest insider trade in VCYT?
Leite John, Global Chief Commercial Off filed a sell (open-market sale) of 4.01K sh worth $160.60K on Sep 21, 2026.
Which institutions changed their VCYT positions?
Recent 13F filers moving the stock include ARK Investment Management.
Other diagnostics & research stocks
Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.
Get a text when insiders, Congress or big funds trade a stock.
Free. Reply STOP anytime.